A detailed history of Pacific Center For Financial Services transactions in Biogen Inc. stock. As of the latest transaction made, Pacific Center For Financial Services holds 71 shares of BIIB stock, worth $16,246. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71
Previous 71 -0.0%
Holding current value
$16,246
Previous $18,000 16.67%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 18, 2021

SELL
$236.26 - $355.63 $1,417 - $2,133
-6 Reduced 7.79%
71 $17,000
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $21,648 - $25,386
77
77 $24,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $33B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Pacific Center For Financial Services Portfolio

Follow Pacific Center For Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Center For Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Center For Financial Services with notifications on news.